Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors

Clinical and Experimental Immunology

Volumn 119, Issue 1, 2000, Pages 225-230

  Le Cleach, L ^a   Delaire, S ^a   Boumsell, L ^a   Bagot, M ^a   Bourgault Villada, I ^a,b   Bensussan, A ^a   Roujeau, J C ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b HÔPITAL AMBROISE PARÉ   (France)

Author keywords

Cutaneous drug adverse reaction; Cytotoxic T lymphocytes; Killer inhibitory receptors; Toxic epidermal necrolysis

Indexed keywords

ADULT; ARTICLE; BLISTER; CASE REPORT; CYTODIAGNOSIS; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; INFLAMMATORY INFILTRATE; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; SKIN BIOPSY; TOXIC EPIDERMAL NECROLYSIS;

ADULT; ANTIGENS, CD3; ANTIGENS, CD8; BLISTER; BODY FLUIDS; CYTOTOXICITY, IMMUNOLOGIC; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HUMANS; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033956005     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01119.x     Document Type: Article

References (21)

1. 1 Roujeau JC, Stern R. Severe adverse cutaneous reaction to drugs. N Engl J Med 1994; 331:1272-85.
2. 2 Paul C, Wolkenstein P, Adle H, Wechsler J, Garchon HJ, Revuz J, Roujeau JC. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol 1996; 134:710-4.
3. 3 Viard I, Wehrli P, Bullani R et al. Inhibition of toxic epidermal necrolysis by blockage of CD95 with human intravenous immunoglobulin. Science 1998; 282:490-3.
4. 4 Hertl M, Geisel J, Boecker C, Merk HF. Selective generation of CD8+ T-cell clones from the peripheral blood of patients with cutaneous reactions to beta-lactam antibiotics. Br J Dermatol 1993; 128:619-26.
5. 5 Mauri-Hellweg D, Bettens F, Mauri D, Brander C, Huntziker T, Pichler WJ. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phentytoin, and carbamazepine. J Immunol 1995; 155:462-72.
6. 6 Schnyder B, Mauri-Hellweg D, Zanni M, Bettens F, Pichler WJ. Direct MHC-dependent presentation of the drug sulfamethoxazole to human T cell clones. J Clin Invest 1997; 100:136-41.
7. 7 Schnyder B, Frutig K, Mauri-Hellweg D, Limat A, Yawalkar N, Pichler WJ. T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazol-induced skin reaction. Clin Exp Allergy 1998; 28:1412-7.
8. 8 Miyauchi H, Hosokawa H, Akaeda T, Iba H, Asada Y. T-cell subsets in drug-induced toxic epidermal necrolysis. Arch Dermatol 1199; 1:851-5.
9. 9 Villada G, Roujeau JC, Clérici T, Bourgault I, Revuz J. Immunopathology of toxic epidermal necrolysis. Arch Dermatol 1992; 128:50-3.
10. 10 Paquet P, Nikkels A, Arrese JE, Vanderkelen A, Piérard GE. Macrophage and tumor necrosis factor α in toxic epidermal necrolysis. Arch Dermatol 1994; 130:605-8.
11. 11 Correia O, Delgado L, Ramos JP, Resende C, Fleming, Torrinha JA. Cutaneous T-cell recruitment in toxic epidermal necrolysis. Arch Dermatol 1993; 129:466-8.
12. 12 Schiavon V, Roth P, Bolton WE, Farcet JP, Bensussan A, Boumsell L. Lymphocyte subsets in normal individuals: analysis by four color immunofluorescence and flow cytometry on whole blood. Tissue Antigens 1996; 48:312-8.
13. 13 Bensussan A, Gluckman E, El Marsafy S et al. BY55 monoclonal antibody delineates within human cord blood and bone marrow lymphocytes distinct cell subsets mediating cytotoxic activity. Proc Natl Acad Sci USA 1994; 91:9136-40.
14. 14 Bagot M, Echakir H, Mami-Chouaib F et al. Isolation of tumor specific cytotoxic CD4+ and CD4+CD8+ dim+ T cell clones infiltrating a cutaneous T cell lymphoma. Blood 1998; 91:433-41.
15. 15 David V, Bourge JF, Guglielmi P, Mathieu-Mahul D, Degos L, Bensussan A. Human T cell clones used a CD3-associated surface antigen recognition structure to exhibit both NK-like and allogeneic cytotoxic reactivity. J Immunol 1987; 138:2831-6.
16. 16 Moretta A, Sivori S, Vitale M et al. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med 1995; 182:875-84.
17. 17 Mingari MC, Ponte M, Bertone S et al. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen-or alloantigen-activated CD8+ T cells. Proc Natl Acad Sci USA 1998; 95:1172-7.
18. 18 Litwin V, Gumpertz JE, Parham P, Phillips JH, Lanier LL. NKB1: an NK cell receptor involved in the recognition of polymorphic HLA-B molecules. J Exp Med 1994; 180:537-43.
19. 19 Mingari MC, Moretta A, Moretta L. Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses. Immunol Today 1998; 19:153-7.
20. 20 De Boer OJ, Hors E, Pals ST, Bos JD, Das PK. Functional evidence that the HECA-452 antigen is involved in the adhesion of human neutrophils and lymphocytes to tumor necosis factor-alpha-stimulaled endothelial cells. Immunology 1994; 81:359-65.
21. 21 Mowat AMcI, Viney JL. The anatomical basis of intestinal immunity. Immunol Rev 1997; 156:145-66.